These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 28491492)

  • 1. Associations between hippocampal morphometry and neuropathologic markers of Alzheimer's disease using 7 T MRI.
    Blanken AE; Hurtz S; Zarow C; Biado K; Honarpisheh H; Somme J; Brook J; Tung S; Kraft E; Lo D; Ng DW; Vinters HV; Apostolova LG
    Neuroimage Clin; 2017; 15():56-61. PubMed ID: 28491492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between hippocampal atrophy and neuropathology markers: a 7T MRI validation study of the EADC-ADNI Harmonized Hippocampal Segmentation Protocol.
    Apostolova LG; Zarow C; Biado K; Hurtz S; Boccardi M; Somme J; Honarpisheh H; Blanken AE; Brook J; Tung S; Lo D; Ng D; Alger JR; Vinters HV; Bocchetta M; Duvernoy H; Jack CR; Frisoni GB;
    Alzheimers Dement; 2015 Feb; 11(2):139-50. PubMed ID: 25620800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-year Follow-up Study of Hippocampal Subfield Atrophy in Alzheimer's Disease and Normal Aging.
    Madusanka N; Choi HK; So JH; Choi BK; Park HG
    Curr Med Imaging Rev; 2019; 15(7):699-709. PubMed ID: 32008518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amygdala atrophies in specific subnuclei in preclinical Alzheimer's disease.
    Salman Y; Gérard T; Huyghe L; Colmant L; Quenon L; Malotaux V; Ivanoiu A; Lhommel R; Dricot L; Hanseeuw BJ;
    Alzheimers Dement; 2024 Oct; 20(10):7205-7219. PubMed ID: 39254209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study.
    Josephs KA; Dickson DW; Tosakulwong N; Weigand SD; Murray ME; Petrucelli L; Liesinger AM; Senjem ML; Spychalla AJ; Knopman DS; Parisi JE; Petersen RC; Jack CR; Whitwell JL
    Lancet Neurol; 2017 Nov; 16(11):917-924. PubMed ID: 28919059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated Hippocampal Subfield Volumetric Analyses in Atypical Alzheimer's Disease.
    Gabere M; Thu Pham NT; Graff-Radford J; Machulda MM; Duffy JR; Josephs KA; Whitwell JL;
    J Alzheimers Dis; 2020; 78(3):927-937. PubMed ID: 33074228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's Disease Biomarkers Have Distinct Associations with Specific Hippocampal Subfield Volumes.
    Müller-Ehrenberg L; Riphagen JM; Verhey FRJ; Sack AT; Jacobs HIL;
    J Alzheimers Dis; 2018; 66(2):811-823. PubMed ID: 30320590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Hippocampal Subfield Volume Reduction and Plasma Biomarker Changes in Mild Cognitive Impairment and Alzheimer's Disease.
    Cao J; Tang Y; Chen S; Yu S; Wan K; Yin W; Zhen W; Zhao W; Zhou X; Zhu X; Sun Z
    J Alzheimers Dis; 2024; 98(3):907-923. PubMed ID: 38489180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Training labels for hippocampal segmentation based on the EADC-ADNI harmonized hippocampal protocol.
    Boccardi M; Bocchetta M; Morency FC; Collins DL; Nishikawa M; Ganzola R; Grothe MJ; Wolf D; Redolfi A; Pievani M; Antelmi L; Fellgiebel A; Matsuda H; Teipel S; Duchesne S; Jack CR; Frisoni GB;
    Alzheimers Dement; 2015 Feb; 11(2):175-83. PubMed ID: 25616957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volume changes of hippocampal and amygdala subfields in patients with mild cognitive impairment and Alzheimer's disease.
    Qu H; Ge H; Wang L; Wang W; Hu C
    Acta Neurol Belg; 2023 Aug; 123(4):1381-1393. PubMed ID: 37043115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can hippocampal subfield measures supply information that could be used to improve the diagnosis of Alzheimer's disease?
    Kannappan B; Te Nijenhuis J; Choi YY; Lee JJ; Choi KY; Balzekas I; Jung HY; Choe Y; Song MK; Chung JY; Ha JM; Choi SM; Kim H; Kim BC; Jo HJ; Lee KH
    PLoS One; 2022; 17(11):e0275233. PubMed ID: 36327265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a histologically validated segmentation protocol for the hippocampal body.
    Steve TA; Yasuda CL; Coras R; Lail M; Blumcke I; Livy DJ; Malykhin N; Gross DW
    Neuroimage; 2017 Aug; 157():219-232. PubMed ID: 28587896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The EADC-ADNI harmonized protocol for hippocampal segmentation: A validation study.
    Zandifar A; Fonov VS; Pruessner JC; Collins DL;
    Neuroimage; 2018 Nov; 181():142-148. PubMed ID: 29966720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort.
    Jarholm JA; Bjørnerud A; Dalaker TO; Akhavi MS; Kirsebom BE; Pålhaugen L; Nordengen K; Grøntvedt GR; Nakling A; Kalheim LF; Almdahl IS; Tecelão S; Fladby T; Selnes P
    J Alzheimers Dis; 2023; 94(1):259-279. PubMed ID: 37248900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reference standard space hippocampus labels according to the European Alzheimer's Disease Consortium-Alzheimer's Disease Neuroimaging Initiative harmonized protocol: Utility in automated volumetry.
    Wolf D; Bocchetta M; Preboske GM; Boccardi M; Grothe MJ;
    Alzheimers Dement; 2017 Aug; 13(8):893-902. PubMed ID: 28238738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medial temporal lobe subregional morphometry using high resolution MRI in Alzheimer's disease.
    Wolk DA; Das SR; Mueller SG; Weiner MW; Yushkevich PA;
    Neurobiol Aging; 2017 Jan; 49():204-213. PubMed ID: 27836336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
    Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA
    Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping local hippocampal changes in Alzheimer's disease and normal ageing with MRI at 3 Tesla.
    Frisoni GB; Ganzola R; Canu E; Rüb U; Pizzini FB; Alessandrini F; Zoccatelli G; Beltramello A; Caltagirone C; Thompson PM
    Brain; 2008 Dec; 131(Pt 12):3266-76. PubMed ID: 18988639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing 3T and 1.5T MRI for mapping hippocampal atrophy in the Alzheimer's Disease Neuroimaging Initiative.
    Chow N; Hwang KS; Hurtz S; Green AE; Somme JH; Thompson PM; Elashoff DA; Jack CR; Weiner M; Apostolova LG;
    AJNR Am J Neuroradiol; 2015 Apr; 36(4):653-60. PubMed ID: 25614473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia.
    Bourgeat P; Chételat G; Villemagne VL; Fripp J; Raniga P; Pike K; Acosta O; Szoeke C; Ourselin S; Ames D; Ellis KA; Martins RN; Masters CL; Rowe CC; Salvado O;
    Neurology; 2010 Jan; 74(2):121-7. PubMed ID: 20065247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.